Global Automated DNA and RNA Synthesizer Market Research Report 2021

The global Automated DNA and RNA Synthesizer market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Automated DNA and RNA Synthesizer volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Automated DNA and RNA Synthesizer market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Automated DNA and RNA Synthesizer Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
10-Column DNA and RNA Synthesizer
12-Column DNA and RNA Synthesizer
96-Column DNA and RNA Synthesizer

Segment by Application
Medical
Laboratory
Biochemistry Research Institution

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
General Electric
Thermo Fisher Scientific
Tekna Plasma Systems
BioAutomation Corporation
Polygen GmbH
GlobalSpec
Biolytic Lab Performance
Beckman Coulter
ACTGene
Precision System Science
CSBio
Genscript Biotech
Protein Technologies